Evergen Biotechnologies Overview

  • Founded
  • 2000

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $1.52M

  • Investors
  • 3

Evergen Biotechnologies General Information


Developer of an industrial-scaled technology designed to produce sexed bovine embryos by in vitro fertilization. The company engages in the research, development, production, and distribution of biological products and services related to embryo biotechnologies, including nuclear transfer technology for animal cloning, in vitro and in vivo embryo production, and transgenic animal production, enabling dairy farms to improve cattle genetics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 428 Hartford Turnpike
  • Suite 107
  • Weston, CT 06066
  • United States
+1 (860) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evergen Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 09-Jan-2008 $1.52M 00.000 000.00 Completed Generating Revenue
2. Grant 01-Jan-2008 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) Completed Startup
To view Evergen Biotechnologies’s complete valuation and funding history, request access »

Evergen Biotechnologies Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.0 00.00 00 00.0 00.000
To view Evergen Biotechnologies’s complete cap table history, request access »

Evergen Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
Jie Xu President
You’re viewing 1 of 2 executive team members. Get the full list »

Evergen Biotechnologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
United States Department of Agriculture Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
DowsLake Venture Venture Capital Minority 000 0000 000000 0
To view Evergen Biotechnologies’s complete investors history, request access »